Seeing Is Believing

Currently out of the existing stock ratings of Gary Lieberman, 7 are a HOLD (70%), 2 are a SELL (20%), 1 are a BUY (10%).
Analyst Gary Lieberman, currently employed at WELLS FARGO, carries an average stock price target met ratio of 100% that have a potential upside of 2.73% achieved within 62 days.
Gary Lieberman’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DGX, Quest Diagnostics at 20-Oct-2017.
Analyst best performing recommendations are on DGX (QUEST DIAGNOSTICS).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $6.07 (7.41%) receiving and performance score of 1.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2026
$260
$32.94 (14.51%)
$250
Hold Since 02-Feb-2018
$260
$32.94 (14.51%)
$250
17 days ago
(21-Sep-2026)
22/24 (91.67%)
$15.12 (6.17%)
352
Hold Since 22-Apr-2022
$245
$17.94 (7.90%)
$220
1 months ago
(08-Sep-2026)
20/20 (100%)
$9.5 (4.03%)
276
Hold Since 30-May-2024
$250
$22.94 (10.10%)
$190
2 months 10 days ago
(28-Jul-2026)
5/6 (83.33%)
$14.06 (5.96%)
245
Buy Since 26-Apr-2017
$260
$32.94 (14.51%)
$235
2 months 14 days ago
(24-Jul-2026)
30/31 (96.77%)
$32.14 (14.11%)
557
What Year was the first public recommendation made by Gary Lieberman?